In diabetes, gastric emptying remains stable over time

August 24, 2012
In diabetes, gastric emptying remains stable over time
Gastric emptying of solids and liquids and gastrointestinal symptoms remain stable over time in patients with long-term type 1 and type 2 diabetes, according to a study published online Aug. 13 in Diabetes Care.

(HealthDay)—Gastric emptying of solids and liquids and gastrointestinal symptoms remain stable over time in patients with long-term type 1 and type 2 diabetes, according to a study published online Aug. 13 in Diabetes Care.

Jessica Chang, M.B.B.S., of the University of Adelaide and Royal Adelaide Hospital in Australia, and colleagues examined the natural history of gastric emptying in diabetes using data from 13 patients with diabetes (12 with type 1 and one with type 2). The participants had measurements of gastric emptying, , glycated hemoglobin, upper , and autonomic available from baseline and after 24.7 ± 1.5 years.

The researchers found no change in gastric emptying of solids or liquids, with gastric emptying at follow-up related to baseline emptying. Gastrointestinal symptoms also remained stable over time. Blood glucose concentrations were significantly lower at follow-up, and autonomic function deteriorated significantly.

"In summary, this prospective study indicates that gastric emptying in patients with long-term diabetes is relatively stable over time," the authors write.

Explore further: Mayo Clinic discovery may help diabetic gastric problem

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Mayo Clinic discovery may help diabetic gastric problem

September 25, 2008

Mayo Clinic researchers have found what may provide a solution to one of the more troubling complications of diabetes -- delayed gastric emptying or gastroparesis. The researchers showed in animal models that a red blood ...

A potential treatment for gastric motility disorders

June 10, 2009

GES or pacing has been under investigation as a potential therapy for gastrointestinal motility disorders. Conventionally, GES is performed using a single pair of electrodes or single-channel GES. However, few studies have ...

Pramlintide improves glucose control in type 1 diabetes

July 25, 2012

(HealthDay) -- The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving insulin through an external ...

Recommended for you

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.